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Abstract
Background Total Parenteral Nutrition (TPN) is a life-saving intervention which provides
nutrition to premature infants with immature gut functioning. Though essential for nutrition
provision in the first days of life, TPN is not without risk. Therefore, it is important to introduce
feedings into the gut and to wean off TPN when able. During this weaning phase, calorie and
protein deficits have been observed to occur. Very few studies have investigated TPN weaning
periods, and there are no studies on malnutrition associated with the TPN weaning period in
premature infants.
Methods This study employed a retrospective chart review, with medical records from a Level
IV Midwest Neonatal Intensive Care Unit (NICU). Subjects were premature infants born
between November 1, 2017 and June 30, 2018, weighing less than 1500 grams at birth, who
received TPN for greater than two days during their hospital stay. Z-scores for weight, length,
and head circumference were calculated and the change in weight z-score was used to assign
malnutrition categories based on recommendations from the proposed methodology. Pearson’s
Chi-Square for association and Kendall’s tau correlation tests were conducted to assign
significance between differences and to understand relationships between variables.
Results There was a significant positive correlation between TPN wean length and overall
malnutrition, indicating that malnutrition incidence increased as TPN wean length increased.
Analysis of change in weight z-score indicated a 50% prevalence of any form of malnutrition at
two weeks of age. Upon further investigation, there was a significant difference in means of TPN
wean length between each form of malnutrition (mild, moderate, and severe).
Conclusion The results of this study support the emerging concept that the TPN weaning period
is a phase when malnutrition can start to develop in premature infants. This study demonstrates
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how the proposed malnutrition criteria can be combined with TPN weaning data to add to an
overall picture of growth during the NICU stay. Future research is warranted to confirm these
findings with a larger sample and to establish TPN weaning protocol standards.
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Definitions and Abbreviations

Premature Birth: Birth that occurs before 37 weeks gestational age.1
LBW: Low Birth Weight. Infant born with weight below 2500 grams (5 pounds, 8 ounces).1
VLBW: Very Low Birth Weight. Infant born with weight below 1500 grams (3 pounds, 4
ounces).1
TPN: Total Parenteral Nutrition. Refers to nutrition provided intravenously.1
EN: Enteral Nutrition. Refers to nutrition provided directly to the gastric or jejunal region.1
Growth z-score: Standardized measure that represents the anthropometric value as a number of
standard deviations below or above the reference mean or median value.2
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Introduction
Evidence over the past three decades points to widespread cumulative nutritional deficits
and growth failure occurring within the first weeks of life in premature infants.3-5 These deficits
are more likely to occur during the time period of weaning total parenteral nutrition (TPN) to
enteral nutrition.5,6 Despite this knowledge, limited studies have investigated the TPN weaning
period specifically related to malnutrition, and there is a lack of knowledge about prevalence of
neonatal malnutrition during this high-risk transition.
When infants are born prematurely (less than 37 weeks gestation age)1, they may require
total parenteral nutrition (TPN) until their gastrointestinal tract anatomy is developed enough to
tolerate feedings.7-12 During the first few weeks of life, premature infants are at risk for fluid,
protein and caloric deficits.10,13-15 Data suggest that early, aggressive TPN not only provides the
macronutrients required to thrive outside the womb, but supports optimal neurodevelopmental
outcomes.13,16-22 There is evidence of a significant link between energy intake and
neurodevelopmental outcomes at 18 months gestational age for premature infants born weighing
less than 1000 grams.16 For example, for every gram increase in weight, an infant’s score on the
Bayley Mental Developmental index (MDI) is increased.16 The ultimate goal of TPN and enteral
feedings in the premature infant is to achieve a postnatal growth velocity that is similar to
intrauterine growth in infants with the same gestational age.18,21,23,24 When this goal is not met
and an infant experiences growth failure, there is a well-developed association with long-term
neurologic and cognitive impairments.6,17,18,23,25
Prior to discharging home, an infant who was receiving TPN in the hospital must be
weaned to enteral nutrition. During TPN weaning, calorie and protein goals are not always met,
indicating that this may be a time period in the Neonatal Intensive Care Unit (NICU) stay that
8

places the neonate at increased malnutrition risk.6 In fact, 80% of very low birthweight
premature infants that were included within a study conducted by the National Institutes of
Health Neonatal Research Network from 2008-2010 had documented growth failure upon
discharge.6 Additionally, in the year 2013, 50.3% of infants who discharged from hospitals
within the Vermont Oxford Network were classified as growth restricted upon their date of
discharge.6 Despite these findings, the effect of TPN weaning duration on the development of
neonatal malnutrition is not known.
New guidelines to assess malnutrition in premature infants have been proposed by a
group of expert NICU registered dietitian nutritionists and published in the Journal of the
Academy of Nutrition and Dietetics (JAND).25 This new methodology attempts to standardize
and define premature and neonatal malnutrition, and relies on quantitative data such as weight
for age z-scores, and number of days to regain birthweight.25 With these diagnostic criteria in
place, the risk of developing malnutrition during and after TPN weaning, along with the
prevalence of malnutrition during the TPN weaning phase, can now be quantified using a
standardized tool. This study will add to the body of knowledge about the increased risk of the
TPN weaning period, and results may be used in the development of TPN weaning protocols for
optimal growth outcomes and the prevention of malnutrition for premature infants.
Purpose
This study aims to demonstrate the implementation of a recently proposed methodology
for assessing malnutrition in premature infants, and to apply that criteria to infants during the
weaning period from TPN to enteral nutrition. The objective is to understand the prevalence of
neonatal malnutrition during the TPN weaning period.
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Research Questions
1.

What is the prevalence of neonatal malnutrition in infants born prematurely, after
hospitalization that includes TPN weaning?

2.

What is the relationship between malnutrition z-score and TPN wean length?

3.

What is the association between TPN wean length and neonatal malnutrition category?

Significance
In addition to demonstrating the use of proposed malnutrition diagnosis criteria with
premature infants, this study adds an examination of the relationship between attributes of the
TPN weaning period and development of malnutrition in very low birthweight infants born
prematurely. This work will add to the current knowledge by providing a method of quantifying,
and specifying, nutrition risk during the TPN weaning period. Through analysis of secondary
data and use of the neonatal malnutrition diagnostic criteria, this study will add to the current
literature by determining (1) the prevalence of neonatal malnutrition in premature infants after
hospitalization with TPN weaning; (2) the relationship between neonatal malnutrition diagnosis
and TPN weaning length; and (3) the association between categories of neonatal malnutrition
and TPN weaning length.
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Review of Literature
Premature infants often rely on TPN to provide nutrients they otherwise would be
receiving in utero. No study to date has defined the optimal gestational age or weight cut off for
determining which infants receive TPN; however, neonatal intensive care units have been
documented to commonly use less than 30 weeks gestational age and/or less than 1,250 grams
birth weight as criteria.13 Many extend this criteria for TPN initiation to less than 32 weeks
gestational age at birth and/or less than 1,500 grams birthweight, although the risks of TPN
within these older premature infants are not proven to outweigh the benefits.9,12
Despite the multitude of studies available on premature infants receiving TPN, it is
unclear which cut-offs should be used to balance the benefits against the known risks of use of
TPN in infants.4,23 Short term risks identified in TPN use include sepsis, line-misplacement,
catheter related blood stream infection, and parenteral nutrition-associated liver disease
(PNALD).4,18 TPN-induced amino acid imbalances from cysteine and taurine deficiencies and
excessive methionine have been found to lead to hepatic dysfunction.8 Long term risks for
infants on prolonged TPN infusion are still being studied; however, research has found an
association between the aluminum contamination of TPN solutions and decreased bone mass of
preterm infants during adolescence.4
TPN Weaning in the Premature Infant
TPN weaning occurs early in many practices to limit the use of indwelling catheters and
prevent infection risk, with initiation and advancement of enteral feedings often stopped due to
high gastric residuals, abdominal distention, blood transfusions, and changes in medical
status.23,26 Any of these interruptions in nutrient provision can be detrimental to the growth of
infants during this vulnerable phase of TPN weaning.6,23,26
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Currently, there are not clear, evidence-based guidelines established for the best practices
for TPN weaning for premature infants. Instead, preliminary TPN weaning protocols in
published literature have been designed to reduce the risks described above, not specifically to
address growth velocity.4,18,23,27,28 For example, according to the American Society for Parenteral
and Enteral Nutrition (ASPEN) Parenteral Nutrition Safety Consensus Recommendations,
pediatric patients should receive a gradual taper-down period when weaning TPN to prevent
rebound hypoglycemia.28 Evidence suggests that prolonged or recurrent hypoglycemia has been
linked to neurodevelopmental impairment in pediatric patients, including intractable epilepsy,
cerebral palsy, mental motor retardation, and visual disturbances.28 Severe hypoglycemia and
wide glycemic fluctuations in neonates have been associated with neuronal cell death.
Furthermore, hypoglycemia in infants is independently associated with mortality.28
Lack of Pediatric TPN Weaning Evidence
Diversity of practice regarding nutrition support contributes greatly to underfeeding in
neonates; however, there is a documented lack of evidence-based guidelines for pediatric TPN,
which explains the variation in prescribing and weaning.15,29 Although there are guidelines on
estimated nutritive needs while a premature infant is on TPN, there are no standardized
guidelines for the weaning period during which TPN and enteral feedings are being used
simultaneously.30,31 This leaves hospitals to derive their own weaning methods.30,31
Previous studies have suggested that, by standardizing prescribing practices for TPN and
enteral feedings, nutrition provision was improved by increasing caloric and protein intake and
promoting weight gain.10,16,32 A protocol, however, is only useful when it is adhered to. A recent
study indicated frequent discrepancies in what physicians intended to prescribe and what was
actually provided to preterm infants.5 This differences were ultimately found to be physicians
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deviating from the recommendations of their hospital protocols for initiation and dose of TPN
macronutrients.5 Additionally, the length of the TPN wean period has not been well examined.
With previous evidence pointing to the nutrition risk of this time period, the length of time an
infant is placed at increased risk should be explored.
Transition to Enteral Feedings
Enteral feeding has been found to preserve gut integrity, prevent bacterial translocation,
and protect the neonate against parenteral nutrition associated liver disease.30 Therefore,
published recommendations encourage the introduction of feedings into the gut as early as
anatomically possible, usually by day one or two in small amounts.6,25,30 These small trophic
enteral feedings have demonstrated the ability to stimulate the immature intestinal tract to
undergo maturation.25 Until complete maturation, the immature gut is unable to digest and
absorb the needed amounts of nutrients to sustain itself.25 Thus, TPN is needed until substantial
amounts of enteral feedings are tolerated.28 With regular stimulation of the gut, maturation is
estimated to occur within two weeks of the initiation of trophic feedings.10,25,29-30
Evidence shows that during this transitional phase in nutrition provision, where TPN is
being weaned and enteral feedings are advanced, the premature infant is frequently being
underfed.26,32-34 One particular study was able to define a net deficit of protein at 0.6g/kg/day
during the weaning phase, and a maximum intake of 108 kcal/kg/day when compared to a
recommended 120 kcal/kg/day goal during the weaning phase.26 Reasons for this have been
attributed to parenteral nutrition being weaned or terminated too early, delayed initiation of
enteral feedings, inadequate nutrition prescriptions for TPN, inadequate fortification of
breastmilk, and withholding feedings as a reflex to unusual behaviors in hospitalized infants.32-34
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Assessing Growth in the Premature Infant
After they are delivered, all infants will lose weight.35 This postnatal diuresis is expected
and demonstrated in both term infants and premature infants.35 Ideally, newborns will regain
their birthweight within two weeks. However, most premature infants will demonstrate poor
growth in weight gain, length, and head circumference within the first two weeks of life.35
Therefore, when assessing the growth status of premature infants, it is imperative to use the
correct growth charts to plot weight, length, and head circumference. The 2013 Fenton preterm
growth chart or the 2010 Olsen intrauterine growth chart should be exclusively used for infants
born at a gestational ages of 36 6/7 weeks and younger.1,23 Other growth charts do not account
for postnatal diuresis, and therefore are not appropriate for use in the premature infant
population.23
Growth velocity in premature infants has most commonly been assessed with calculations
for increases in grams/kilogram/day of weight.23,25,36 Growth failure had been generally
associated with growth velocity rates less than 15 g/kg/day and less than 0.5-1.0 cm increases in
both length and head circumference.1,25 However, the overall goal of 15 g/kg/day does not
consider the necessary changes in rate of weight gain as birth gestational age and postnatal age
increase.23,25 Alternatively, change in z-scores, which are standard deviation scores, are currently
the preferred method for diagnosing malnutrition.2,25
The Z-score expresses the weight, length or head circumference as a number of standard
deviations below or above the reference median or mean value.2,36 Advantages of interpreting zscores are that they are generalizable to all genders, ages, and racial/ethnic groups.2 Additionally,
trended z-scores are more sensitive to minor, but cumulative, changes in anthropometric values
when compared to trended percentiles.2 When calculated regularly, z-scores allow the
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practitioner to analyze whether an infant is maintaining growth or gaining above or below the
intrauterine standards.36
Additionally, previous research has demonstrated that declining trends of weight-based zscores are significantly associated with extrauterine growth restriction in premature infants, as a
result of undernutrition.36 This lends support to the idea that using z-scores, specifically the
weight based z-scores, may assist with early prediction of malnutrition in premature infants.36
Malnutrition in the Premature Infant
Malnutrition in the premature infant has been investigated; however, there has been
considerable variation in terminology and criteria used to define it. In 2012, a journal article
published within the Turkish Journal of Pediatrics investigated fetal malnutrition, calling it
“morphological change” and using a clinical nutrition status score based on physical parameters
alone.37 A 2012 article published within the Journal of Parenteral and Enteral Nutrition
interchangeably used the terms “severe acute malnutrition” and “kwashiorkor” when referring to
premature very low birthweight infants.38 Many published papers have used the terminology
“growth failure” when referring to undernutrition.39 The lack of standardization of terms and
methods to describe malnutrition has made it difficult to track prevalence rates, or to determine
which methods of diagnosis and monitoring are reliable and consistent.
In September 2018, the Academy of Nutrition and Dietetics (AND) published newly
proposed diagnostic criteria to identify malnutrition in the preterm and neonatal populations.25
The primary indicators for malnutrition include: weight-for-age z-score, weight gain velocity,
nutrient intake, days to regain birthweight, linear growth velocity, and decline in length-for-age
z-score. Diagnoses are further classified into mild, moderate, and severe malnutrition.25 By using
a weight-for-length z-score change between birth and two weeks of age, the proposed
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malnutrition criteria account for both postnatal diuresis and time to regain birthweight. These
guidelines were developed by a committee comprised of experienced NICU registered dietitian
nutritionists. The committee utilized literature review and group consensus, and used a
methodology similar to the consensus statement of the AND and ASPEN on pediatric
malnutrition.25
Multiple factors can influence the development of malnutrition in premature infants. The
risk for premature infants originates within their reduced nutrient stores at birth and inadequate
nutrient absorption, and often increases with delayed parenteral and enteral nutrition
advancement.25,36 Malnutrition in the neonatal period should not be taken lightly; in the NICU,
undernutrition has been associated with unfavorable clinical outcomes including sepsis, chronic
lung disease, and prolonged mechanical ventilation.34 And the effects of malnutrition are farreaching; research indicates a clear link between poor growth in premature infants and poor
neurocognitive development later in adolescence.16,36,38,39 All of these factors make it important
that malnutrition in premature neonates be studied and understood, so that preventable causes of
malnutrition that can be addressed in this vulnerable population.
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Materials and Methods
Design
This study used a retrospective chart review design, with data abstracted from electronic
medical records from the time period November 1, 2017- June 30, 2018 in a Level IV Midwest
NICU.
Subject Selection
Inclusion criteria
Infants with the following ICD 10 codes for premature birth (P07.2-P07.39) and for
birthweight of 1500 grams or less (P07.1-P07.16) were included in this study. Subjects must also
have received TPN within their hospital stay for at least two continuous days or longer.
Exclusion criteria
Infants with any of the following ICD 10 code diagnoses during the hospital admission
were excluded from the study: P76-P78, digestive system disorders of newborn including short
gut syndrome and necrotizing enterocolitis; P 29.0-P29.9, cardiovascular disorders originating in
the perinatal period; Q20-Q28, congenital malformations of the circulatory system; Q90-Q91,
Trisomy 18 and Trisomy 21; Q05, spina bifida; Q87.1, Prader-Willi syndrome, and G80.1-80.9,
cerebral palsy. These diagnoses have been found to have associated feeding intolerances and
anecdotally may take longer to wean from TPN or may have disease-associated altered growth
patterns.11-13
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Data Description
The following data elements were requested from the electronic medical records of the
selected premature infants for this study: birth gestational age, birth date, date of admission,
daily weight (in grams), weekly length (in centimeters), weekly head circumference (in
centimeters), date of TPN administration, date of enteral breastmilk administration, and
diagnoses from initial birth encounter.
Sample Size Determination
After data abstraction by a biostatistician, based on inclusion and exclusion diagnostic
criteria, there were 65 case records returned of infants who received TPN for at least two days
during the study period. Of these, 26 infants were born with very low birthweight. One of these
infants expired and was removed from the study, and an additional infant was not able to be
successfully weaned from TPN and was removed from the study.
Calculated Variables
The full TPN time period included the initiation of TPN to the last day of solely provided
TPN. The TPN weaning period was defined as the number of days from the day peak volume of
TPN was decreased until full enteral feedings were in place and TPN was stopped. The full
enteral time period was defined as the first day that TPN was not written for and enteral feedings
were the sole source of nutrition.
Growth velocity using z-scores were assessed on each of three measures (weight, length,
and head circumference), then averaged over the full TPN period, the TPN weaning period, and
the full enteral nutrition period. Additionally, the z-score change within these three time periods
was also calculated.
18

Z-scores were calculated from weight, length, and frontal occipital circumference using
PediTools, which compares growth measures with growth standards from the Fenton 2013
Growth Charts.40 This website tool allows the user to utilize the Fenton, Olsen, and WHO growth
charts for interpretation of weights, lengths, and head circumferences.40
For each infant included in the sample, a malnutrition z-score was calculated according to
the proposed criteria from the Academy of Nutrition and Dietetics, by calculating the change in
weight-for-age z-score from birth to 2 weeks of life.25
From this malnutrition z-score, categories of malnutrition are as follows25:
•

Z-score of -0.8-1.2 standard deviations denotes mild malnutrition.

•

Z-score of >-1.2-2 standard deviations denotes moderate malnutrition.

•

Z-score of >-2 standard denotes severe malnutrition.

Data Management
Data were transmitted to the researcher’s password protected computer and kept in a
locked office on-site at the hospital where the medical records originated. These data will be
stored on the password-protected computer for six years following completion of the study.
Statistical Analyses
As part of data exploration, we tested the assumptions of skewness and kurtosis using
Kolmogorov-Smirnov tests.41 Results revealed violations of these assumptions of normality for
TPN wean length. Based on this finding, nonparametric tests Pearson’s chi-square and Kendall’s
tau for correlation were chosen for the data analyses.41 Based on correlation coefficient r effect
size power analysis, a power of .90 for p value of .10, was achieved with a minimum of 24
subjects in the Kendall’s tau correlation test.
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Following basic descriptive analyses of the research subjects, statistical analyses utilizing
SPSS v. 2242 were performed to answer the research questions. See Table 1 for the research
questions matched to variables and statistical tests. Anthropometric z-scores (weight, length and
head circumference) were compared across time periods (TPN full-strength, TPN weaning
period, and full enteral feeding). The change in z-score was analyzed during these periods.
Change in weight z-scores were analyzed for association with length of TPN weaning period.
Finally, malnutrition categories were assigned for infants based on the weight for age z-score
criteria proposed by the Academy of Nutrition and Dietetics when the infants are at least 2 weeks
of age.25
Table 1. Research questions aligned with data variables and statistical analyses performed.
Research Question

Data Variables

1. What is the prevalence of neonatal
malnutrition in infants born
prematurely, after hospitalization
including TPN weaning?

Change in z-score
for weight from
birth to 2 weeks,
(Malnutrition z
score)

•

Percent and n by all malnutrition
and by malnutrition category.

2. What is the relationship between
malnutrition z-score and TPN wean
length?

Birthweight/age z
score; 2 wk/age z
score; TPN wean
length (days)

•

Kendall’s tau correlation

3. Is there an association between
TPN wean length and neonatal
malnutrition category?

Malnutrition
category, TPN wean
length

•

Average wean length of each
group (no, mild, mod, severe)
Pearson’s Chi-square
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Statistical Analyses

•

Results
The mean birth gestational age for the infants in this study was 29 weeks with an average
birthweight of 1148 grams. The TPN wean lengths ranged from three to 42 days, with a mean
average wean length of 8.29 days. Complete results of the descriptive statistics are shown in
Table 2.
Table 2. Descriptive statistics of study sample, by measurement type and time period, lowbirthweight infants in a Level III NICU Michigan, 2017-18.
Measurement

N

Birthweight (grams)
Weight (Average Z-score)
Full TPN
Wean
Full Enteral
Linear growth (Average Z-score)
Full TPN
Wean
Full Enteral
FOCa (Average Z-score)
Full TPN
Wean
Full Enteral
Change in Z-score
Weight
Length
FOC
Gestational Age at Birth (weeks)

24

1147.88

Standard
Deviation
270.86

23
24
23

0.34
0.88
-1.00

0.86
0.69
0.76

23
21
24

-0.25
-0.63
-0.89

0.85
0.96
0.89

23
21
24

0.36
-1.26
-1.12

1.09
0.94
1.26

22
23
23
24

-0.64
-0.71
-0.73

0.64
0.77
1.27

TPN Wean Length (days)

24

29.04

3.13

8.29

8.08

a

Mean

Frontal occipital circumference
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By two weeks of age, 50% of the infants in this study (n=12) met the criteria for any form
of malnutrition; 29% (n=7) developed mild malnutrition, 17% (n=4) developed moderate
malnutrition, and 4% (n=1) met criteria for severe malnutrition.
Correlation and Chi-Square Analyses
The Kendall’s tau correlation test was used to examine the relationship between length of
the TPN wean the malnutrition z-score (change in z-score from birth to two weeks of age).
Results indicated a significant negative correlation, 𝜏𝜏𝜏𝜏= -.408, p=.008, such that as the length of
the TPN weaning period increased, the z-score indicating malnutrition became more negative.

This indicates that infants with a longer TPN wean were more likely to meet the malnutrition zscore threshold for a diagnosis of any category of malnutrition.
A Pearson’s chi-square test was performed to ascertain the significance of the difference
in TPN weaning length by malnutrition category (mild, moderate, or severe). There was a
significant association, χ2 (27) = 48.36, p=.007, between average length of TPN wean and
malnutrition category, with longer wean lengths associated with greater severity of malnutrition.
The single case of severe malnutrition resulted from a TPN wean of almost double the mean
duration of the sample, at 16 days.
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Discussion
This study found that the proposed criteria recently published by the Academy of
Nutrition and Dietetics are an easily implemented methodology for assessing growth in preterm
infants. Use of this criteria lent additional support to previously published findings that indicate
very low birthweight infants on TPN may be at risk for developing growth deficits. The results
of this study add to the proposed methodology for establishing a malnutrition diagnosis by
specifying the relationship between TPN wean length and the occurrence of neonatal
malnutrition. Contributing to the knowledge on this subject, this study found that longer TPN
wean lengths are correlated with a diagnosis of malnutrition. Additionally, these results suggest
that, once weaning has begun, the longer an infant remains on TPN the greater the degree of
malnutrition that may be diagnosed. These findings further endorse the need for standardized
nutrition strategies and recommendations to be developed for TPN weaning in this specific
population.
In our demonstration using retrospectively collected NICU records, the proposed criteria
for neonatal malnutrition were easy to implement with available clinical data. Because clinicians
employed in the field of neonatology already have access to the information needed to diagnose
premature infants and neonates with malnutrition, employing this methodology for diagnosing
malnutrition, in many cases, can be initiated without additional calculations or effort on the
practitioner’s side. Considering that some electronic medical records automatically calculate the
z-scores when displayed on a growth chart, change in weight z-score would be simple and easy
to compute when assessing these infants. This method is supported by recent literature; the
difference in weight-for-age z-score at birth and two weeks of life has been highlighted by two
2018 studies as a more rational way to analyze growth than assessing the weight z-score alone,
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as it depicts growth faltering rather than poor initial weight z-score and trend.44,45 Additionally,
z-s cores have been found to have a high sensitivity and specificity at their respective time points,

and are statistically significant in predicting growth faltering.43 Therefore, they are instrumental
in the monitoring and development of malnutrition within premature infants, and their use should
be encouraged when assessing growth in this specific population.25
We found a 50% overall malnutrition rate within our sample, which does not deviate
from previous findings. In an article published in 1994, the rate of fetal malnutrition was found
to be 54.0%.46 A 1999 study on fetal malnutrition boasted a malnutrition prevalence rate of
19.6%.47 Two separate studies in 2008 and 2011 relied on a tool that analyzed the physical signs
of malnutrition and reported a 29.97% incidence of overall malnutrition, and a 54.8% of
malnutrition for their SGA infants, respectively.37,48 In 2015, the Von Network released a 50.3%
growth failure figure, and most recently, a 2018 study predicting growth failure among very low
birthweight infants reported a similar rate of 45.5%.39 The lack of standardization to interpret
growth velocity and determine malnutrition in this population makes comparisons between
studies difficult; however, similar incidences of undernutrition have been documented in this
population, leading us to believe that the tool developed by the Academy to diagnose
malnutrition is sound.
One of the strengths of our study was the ability to derive important information
regarding malnutrition from research data, including the identification of a trend occurring
within the TPN weaning period. With hospital tools being utilized for anthropometrics, the
weights were likely to be precise and reliable. Due to the use of the standardized measure of zscores for diagnosis, different criteria for gender were not necessary for the malnutrition
diagnosis.
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Limitations of this study include the possibility of data entry error in the medical records
and missing data. Specifically, weights and gestational age were unavailable from some potential
participants and led to several potential candidates being ineligible for the study. The small
sample size left for analysis limited the statistical power of the results and required the use of
nonparametric tests. Because this study was focused on TPN weaning specifically at a time
period where growth and nutrition is compromised, the findings may not be generalized to
infants solely on enteral nutrition. Due to the specificity of inclusion criteria and specific
neonatal malnutrition criteria, the findings from this study will benefit prematurely born
neonates, and may not be generalizable to term infants, older children and adults. Finally, the
association of TPN wean length and malnutrition risk was revealed during this study; however,
due to the retrospective design of this study, cause-and-effect relationships cannot be established.
Future research is warranted on standardized methods for TPN weaning for premature
infants, to reduce malnutrition in this vulnerable population. Current strategies include volumebased weaning and percentage-based weaning. Volume-based suggestions exist from researchers
in the neonatal field such as Embleton and Simmer11, who recommend decreasing parenteral
nutrition as enteral volumes increase, with special attention to total volume staying in the 150175 mL/kg/day range. They recommend ceasing TPN once enteral feedings are providing 125150 ml/kg/day. However, they do not recommended specific target ranges for macronutrients.
Percentage-based weaning suggestions for TPN weaning in children recommend weaning by a
small percentage every week, but do not offer further guidance, such as the duration of the wean
for neonates.8
The findings of this study may be useful for NICUs that are developing their own TPN
weaning practices, and may deter practitioners from excessive prolongation of TPN weaning in
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this population. If larger studies continue to prove that TPN wean duration is associated with
diagnoses of neonatal malnutrition, this may encourage more aggressive initiation of enteral
nutrition, and quicker TPN weaning. With more attentiveness to growth parameters during this
time frame, and established TPN weaning protocols in institutions, malnutrition in premature
infants may eventually be reduced.
Conclusion
In response to previously published evidence suggesting that the TPN weaning period
may place infants at risk for inadequate nutrition provision, our study provides preliminary
evidence that the TPN weaning period may also be associated with neonatal malnutrition. We
have demonstrated how to apply the diagnostic criteria proposed for neonatal malnutrition, with
the addition of data on the TPN weaning duration, to complete a picture of growth using
available clinical data for premature infants receiving nutrition support in the first two weeks of
life.
Approximately fifty percent of the infants in this study met the criteria for a neonatal
malnutrition diagnosis. Additionally, we found a significant positive association between the
length of the TPN weaning period and malnutrition diagnosis. We recommend that future
studies investigate the composition of the TPN being used and the necessity behind prolonged
TPN weans. Without clear, evidence-based guidelines for TPN weaning in premature infants,
this period is likely to continue to be a critical area for adequate nutrition provision and a risk for
the development of malnutrition.
Considering that malnutrition has been associated with unfavorable clinical outcomes
including sepsis, chronic lung disease, prolonged mechanical ventilation, and poor
neurodevelopmental outcomes, early diagnosis of malnutrition is crucial.34, 51 With the proposed
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guidelines for diagnosing and staging malnutrition in the neonatal population, practitioners can
correct malnutrition as it is developing, and ensure that their protocols for TPN weaning,
including duration, promote adequate nutrition for optimal growth outcomes.
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